DIVA Laboratories, Ltd.

TPEX:4153 Voorraadrapport

Marktkapitalisatie: NT$2.5b

DIVA Laboratories Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

DIVA Laboratories has a total shareholder equity of NT$1.0B and total debt of NT$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NT$1.3B and NT$319.3M respectively. DIVA Laboratories's EBIT is NT$113.0M making its interest coverage ratio -20.9. It has cash and short-term investments of NT$607.7M.

Belangrijke informatie

0%

Verhouding schuld/eigen vermogen

NT$0

Schuld

Rente dekkingsratio-20.9x
ContantNT$607.65m
AandelenNT$1.02b
Totaal verplichtingenNT$319.35m
Totaal activaNT$1.34b

Recente financiële gezondheidsupdates

Geen updates

Recent updates

Should You Be Impressed By DIVA Laboratories' (GTSM:4153) Returns on Capital?

Feb 28
Should You Be Impressed By DIVA Laboratories' (GTSM:4153) Returns on Capital?

DIVA Laboratories, Ltd. (GTSM:4153) Stock's On A Decline: Are Poor Fundamentals The Cause?

Dec 27
DIVA Laboratories, Ltd. (GTSM:4153) Stock's On A Decline: Are Poor Fundamentals The Cause?

Is DIVA Laboratories (GTSM:4153) Likely To Turn Things Around?

Nov 30
Is DIVA Laboratories (GTSM:4153) Likely To Turn Things Around?

Analyse van de financiële positie

Kortlopende schulden: 4153's short term assets (NT$1.1B) exceed its short term liabilities (NT$314.8M).

Langlopende schulden: 4153's short term assets (NT$1.1B) exceed its long term liabilities (NT$4.5M).


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: 4153 is debt free.

Schuld verminderen: 4153 had no debt 5 years ago.

Schuldendekking: 4153 has no debt, therefore it does not need to be covered by operating cash flow.

Rentedekking: 4153 has no debt, therefore coverage of interest payments is not a concern.


Balans


Ontdek gezonde bedrijven